Physician profile
John C Patterson
NPI 1174504997
$1,371.40
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,206 · 2020: $165.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $225.88 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $193.96 | 2019 | |
| Novartis Pharmaceuticals Corporation | $179.30 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $138.92 | 2019-2020 | |
| Novo Nordisk INC | $132.46 | 2019 | |
| Boston Scientific Corporation | $125.00 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $45.75 | 2019 | |
| Abbott Laboratories | $41.50 | 2019 | |
| Actelion Pharmaceuticals US, INC. | $38.29 | 2019-2020 | |
| Amgen INC. | $29.26 | 2019 | |
| Merck Sharp & Dohme LLC | $26.46 | 2019-2020 | |
| Amarin Pharma, INC. | $24.50 | 2020 | |
| Lilly USA, LLC | $24.50 | 2019 | |
| Sanofi-Aventis U.S. LLC | $24.09 | 2019 | |
| Vifor Pharma, INC. | $22.28 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $21.13 | 2019 | |
| Medtronic Minimed, INC. | $21.00 | 2019 | |
| Corcept Therapeutics | $20.08 | 2020 | |
| Sunovion Pharmaceuticals INC. | $19.39 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Patterson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.